NUF2 Promotes Breast Cancer Metastasis via Activating Wnt/β-Catenin Pathways
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2911371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Nijiati AiErken und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, 518107 ShenZhen, Guangdong, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Wnt Signaling Pathway, Cell Movement, Cell Cycle Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Breast cancer is the most common malignancy and the leading cause of cancer death among women. NDC80 kinetochore complex component (NUF2) is demonstrated to implicate the progression of human cancer. But the role of NUF2 in breast cancer progression is unclear. Here, we aimed to study the role and regulatory mechanisms of NUF2 in breast cancer metastasis.
Methods
Immunohistochemistry was used to determine UNF2 expression in clinical samples. Transwell assas were used to determine the role of NUF2 in breast cancer migration and invasion. Animal model in vivo was used to determine the rold of NUF2 in breast cancer metastasis.
Results
NUF2 was upregulated significantly in breast cancer tissues and cells. Worse prognosis was noted in patients with high NUF2 levels compared with that in patients with low NUF2 levels. NUF2 overexpression markedly enhanced, while NUF2 knockdown inhibited, breast cancer cell invasion and migration. Mechanistically, NUF2 was observed to upregulate Wnt/β-catenin signaling pathway activity. The promoting effect of NUF2 on cell migration and invasion were blocked by inhibition of the Wnt/β-catenin pathway.
Conclusions
We revealed that NUF2 promotes breast cancer progression via activating Wnt/β-catenin signaling, suggesting that NUF2 might be a new potential target for breast cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, 518107 ShenZhen, Guangdong, China.
- Department of Microbiology, School of Public Health, Southern Medical University, 510515 Guangzhou, Guangdong, China.
- Department of General Practice, The Seventh Affiliated Hospital, Sun Yat-sen University, 518107 ShenZhen, Guangdong, China.
Zitieren
APA
AiErken, N., Wang, X., Wang, J., Ma, W., Cui, L., Zhang, M., Ma, W., & Liu, D. (2024). NUF2 Promotes Breast Cancer Metastasis via Activating Wnt/β-Catenin Pathways. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2911371
Vancouver
AiErken N, Wang X, Wang J, Ma W, Cui L, Zhang M, et al. NUF2 Promotes Breast Cancer Metastasis via Activating Wnt/β-Catenin Pathways. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2911371
BibTeX
@article{AiErken2024,
author = {AiErken, Nijiati and Wang, Xidi and Wang, Jiamei and Ma, Weisen and Cui, Lingfei and Zhang, Mingxia and Ma, Weifeng and Liu, Dongwei},
title = {NUF2 Promotes Breast Cancer Metastasis via Activating Wnt/β-Catenin Pathways},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2911371}
}
EUVIMED